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I will highlight two technologies developed in my laboratory for the delivery of diverse drugs by genetically 
encoded polymer drug carriers.  First, I will describe a new drug delivery system that we have developed for 
small molecule cancer chemotherapeutics. This methodology —attachment-triggered self-assembly of 
recombinant peptide polymers— can package small molecule cancer drugs with a range of hydrophobicity into 
soluble nanoparticles of a recombinant peptide polymer. These nanoparticles increase the solubility, plasma 
half-life, and tumor accumulation of the drug, which translates to improved efficacy of the nanoparticle 
formulation as compared to free drug.  Examples of encapsulating doxorubicin, paclitaxel, and gemcitabine —
three drugs with vastly different structures and physico-chemical properties— will be presented to illustrate the 
versatility of this new technology for drug delivery. I will also discuss an injectable delivery system based on 
thermally sensitive polypeptides for the sustained and tunable release of peptide drugs from a subcutaneous 
injection site that we have developed for treatment of type 2 diabetes. 
 
 
